Ni Jiang Selected Research

Esophageal Achalasia (Megaesophagus)

3/2023

A comprehensive analysis of partial peristalsis recovery after peroral endoscopic myotomy in patients with achalasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ni Jiang Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 01/2015
5	Adenocarcinoma of Lung 04/2023 - 09/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2019
3	Hypoxia (Hypoxemia) 01/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2023 - 09/2017
2	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2022
2	Schistosomiasis (Bilharziasis) 03/2022 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2014 - 12/2006
1	Tissue Adhesions 03/2024
1	Bites and Stings (Sting) 03/2024
1	Lymphatic Metastasis 04/2023
1	Esophageal Achalasia (Megaesophagus) 03/2023
1	Jaundice (Icterus) 02/2023
1	Hemolytic Anemia 02/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Anemia 01/2023
1	Anorexia 01/2023
1	Fatigue 01/2023
1	Leukopenia 01/2023
1	Nausea 01/2023
1	Vomiting 01/2023
1	Postpartum Depression (Post-Natal Depression) 01/2023
1	Ischemic Stroke 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	COVID-19 10/2020
1	Infections 10/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2020
1	Leukemia 03/2020
1	Hyperthermia 11/2019
1	Endometrial Neoplasms (Endometrial Cancer) 11/2019
1	Thrombosis (Thrombus) 05/2019

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2017
4	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 10/2020
2	CytokinesIBA 01/2023 - 11/2019
2	Long Noncoding RNAIBA 04/2022 - 01/2022
2	Niclosamide FDA Link 03/2022 - 10/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2019
2	Peptide Hydrolases (Proteases)FDA Link 03/2020 - 01/2020
1	ProdrugsIBA 03/2024
1	gambogic acidIBA 03/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 03/2024
1	Hyaluronic Acid (Hyaluronan)IBA 03/2024
1	InterferonsIBA 03/2024
1	UbiquitinIBA 11/2023
1	Matrix Metalloproteinases (MMPs)IBA 05/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2023
1	1-methyl-1H-indole-2-carboxylic acid (4- (1- (4- (4- acetylpiperazin- 1- yl)cyclohexyl)- 4- amino- 1H- pyrazolo(3,4- d)pyrimidin- 3- yl)- 2- methoxyphenyl)amideIBA 05/2023
1	Microfilament Proteins (Actin Binding Proteins)IBA 05/2023
1	dactolisibIBA 05/2023
1	cytochrome P-450 CYP4B1 (CYP4B1)IBA 04/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2023
1	Cyclin D1IBA 03/2023
1	Hemoglobins (Hemoglobin)IBA 02/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	Tuberculin (PPD)IBA 01/2023
1	Aurora Kinase AIBA 01/2023
1	Cyclin B1IBA 12/2022
1	IntegrinsIBA 04/2022
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 01/2022
1	Protein CoronaIBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Nerve Growth Factor (NGF)IBA 01/2022
1	tislelizumabIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2021
1	sinomenineIBA 01/2021
1	AntioxidantsIBA 10/2020
1	VaccinesIBA 10/2020
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2020
1	CatalaseIBA 10/2020
1	EnzymesIBA 10/2020
1	Cysteine (L-Cysteine)FDA Link 03/2020
1	AcidsIBA 03/2020
1	Molecular Probes (Molecular Probe)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2019
1	pembrolizumabIBA 11/2019
1	Interleukin-4 (Interleukin 4)IBA 11/2019
1	Interleukin-2 (IL2)IBA 11/2019
1	Circulating Tumor DNAIBA 09/2019
1	ErbB Receptors (EGF Receptor)IBA 09/2019
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2019
1	AnticoagulantsIBA 05/2019

Therapy/Procedure

9	Immunotherapy 03/2024 - 09/2017
6	Therapeutics 01/2023 - 01/2017
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
1	Myotomy 03/2023
1	Radiotherapy 01/2023
1	Transplantation 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019
1	Blood Component Removal (Apheresis) 05/2019
1	Catheters 05/2019